Guidant's Purchase Price For Sulzer Hinges On Final Sales Rep Conversion
This article was originally published in The Gray Sheet
Executive Summary
The extent to which Guidant's $775 mil.-plus Sulzer acquisition alters the landscape of the bradycardia pacing market depends in large part on the number of Sulzer electrophysiology sales reps that agree to join Guidant's sales organization.